Matches in Wikidata for { <http://www.wikidata.org/entity/Q92271829> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q92271829 description "clinical trial" @default.
- Q92271829 description "ensayo clínico" @default.
- Q92271829 description "ensayu clínicu" @default.
- Q92271829 description "klinisch onderzoek" @default.
- Q92271829 description "клінічне випробування" @default.
- Q92271829 description "临床试验" @default.
- Q92271829 name "Almonertinib Versus Paclitaxel Plus Carboplatin as First-line Treatment in Patients With EGFR Mutation Positive Locally Advanced or Metastatic Pulmonary Adenosquamous Carcinoma （ARISE）" @default.
- Q92271829 name "Almonertinib Versus Paclitaxel Plus Carboplatin as First-line Treatment in Patients With EGFR Mutation Positive Locally Advanced or Metastatic Pulmonary Adenosquamous Carcinoma （ARISE）" @default.
- Q92271829 type Item @default.
- Q92271829 label "Almonertinib Versus Paclitaxel Plus Carboplatin as First-line Treatment in Patients With EGFR Mutation Positive Locally Advanced or Metastatic Pulmonary Adenosquamous Carcinoma （ARISE）" @default.
- Q92271829 label "Almonertinib Versus Paclitaxel Plus Carboplatin as First-line Treatment in Patients With EGFR Mutation Positive Locally Advanced or Metastatic Pulmonary Adenosquamous Carcinoma （ARISE）" @default.
- Q92271829 prefLabel "Almonertinib Versus Paclitaxel Plus Carboplatin as First-line Treatment in Patients With EGFR Mutation Positive Locally Advanced or Metastatic Pulmonary Adenosquamous Carcinoma （ARISE）" @default.
- Q92271829 prefLabel "Almonertinib Versus Paclitaxel Plus Carboplatin as First-line Treatment in Patients With EGFR Mutation Positive Locally Advanced or Metastatic Pulmonary Adenosquamous Carcinoma （ARISE）" @default.
- Q92271829 P1050 Q92271829-8434D6CE-CE8E-4872-AA00-011D12209CE6 @default.
- Q92271829 P1132 Q92271829-09C3C45B-E958-4554-B5CE-403303776A4C @default.
- Q92271829 P1476 Q92271829-D6B6FFCD-126D-4C5C-8BCF-68355AEC4748 @default.
- Q92271829 P1813 Q92271829-8F42B801-2A8A-4E2C-B1EE-5A46FA20B442 @default.
- Q92271829 P2899 Q92271829-11BD5369-AE71-4281-8F06-5BE399196C00 @default.
- Q92271829 P3098 Q92271829-A5A337B8-7F82-46AE-9DE8-F6E3A9E3A2F3 @default.
- Q92271829 P31 Q92271829-B1819689-4F60-4A97-9A80-0D022381251C @default.
- Q92271829 P4135 Q92271829-9407E121-64EE-4EF4-AF40-DE0EED3B9D59 @default.
- Q92271829 P4844 Q92271829-1333CD7B-53B3-440E-89BD-2C6988F74022 @default.
- Q92271829 P4844 Q92271829-C654AF1E-A589-43B1-9FAD-8CD627211305 @default.
- Q92271829 P580 Q92271829-C1387163-D8D4-44DD-B423-8D42E97E47CD @default.
- Q92271829 P582 Q92271829-3EBC52BC-EECD-47E9-9C50-CD190587B300 @default.
- Q92271829 P6099 Q92271829-7BC8014A-3170-429F-A3E7-09E426F1132D @default.
- Q92271829 P8005 Q92271829-5B70A7D4-8694-42D2-808F-ABE9C38E9ED1 @default.
- Q92271829 P8363 Q92271829-8AE4A922-CB8E-47BA-A7A0-100626148105 @default.
- Q92271829 P1050 Q33525 @default.
- Q92271829 P1132 "+134" @default.
- Q92271829 P1476 "Almonertinib Versus Paclitaxel Plus Carboplatin as First-line Treatment in Patients With Epidermal Growth Factor Receptor (EGFR) Mutation Positive Locally Advanced or Metastatic Pulmonary Adenosquamous Carcinoma: A Multicenter, Open-label, Randomized, Control Phase II Study（ARISE）" @default.
- Q92271829 P1813 "ARISE" @default.
- Q92271829 P2899 "+18" @default.
- Q92271829 P3098 "NCT04354961" @default.
- Q92271829 P31 Q30612 @default.
- Q92271829 P4135 "+75" @default.
- Q92271829 P4844 Q415588 @default.
- Q92271829 P4844 Q423762 @default.
- Q92271829 P580 "2020-06-01T00:00:00Z" @default.
- Q92271829 P582 "2023-05-01T00:00:00Z" @default.
- Q92271829 P6099 Q42824440 @default.
- Q92271829 P8005 Q76649614 @default.
- Q92271829 P8363 Q78089383 @default.